IDA
MRNA icon

Intelligence Driven Advisers’s Moderna MRNA Stock Holding History

Intelligence Driven Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,846
Closed -$945K – 96
2021
Q3 		$945K Hold
2,846
– – 0.21% 40
2021
Q2 		$669K Buy
2,846
+4
+0.1% +$715 0.13% 51
2021
Q1 		$372K Sell
2,842
-15
-0.5% -$2.17K 0.08% 61
2020
Q4 		$298K Sell
2,857
-1,143
-29% -$116K 0.07% 82
2020
Q3 		$283K Buy
+4,000
New +$279K 0.07% 69

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Intelligence Driven Advisers's MRNA Position: Q4 2021 in Review

Intelligence Driven Advisers sold out of Moderna (MRNA) in Q4 2021, closing a stake of 2,846 shares — an estimated $945K sold.

Intelligence Driven Advisers first reported a position in MRNA in Q3 2020 and held it in 5 quarters. The position peaked at $945K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Intelligence Driven Advisers reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Intelligence Driven Advisers sold 2,846 Moderna shares in Q4 2021, an estimated $945K.
  • Intelligence Driven Advisers first reported a position in Moderna in Q3 2020 and held it in 5 quarters.
  • Intelligence Driven Advisers's Moderna position peaked at $945K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Intelligence Driven Advisers's 13F filing for Q4 2021, filed 19 Jan 2022.